<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34774801</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>297</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Phase-separated protein droplets of amyotrophic lateral sclerosis-associated p62/SQSTM1 mutants show reduced inner fluidity.</ArticleTitle><Pagination><StartPage>101405</StartPage><MedlinePgn>101405</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101405</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2021.101405</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(21)01212-6</ELocationID><Abstract><AbstractText>Several amyotrophic lateral sclerosis (ALS)-related proteins such as FUS, TDP-43, and hnRNPA1 demonstrate liquid-liquid phase separation, and their disease-related mutations correlate with a transition of their liquid droplet form into aggregates. Missense mutations in SQSTM1/p62, which have been identified throughout the gene, are associated with ALS, frontotemporal degeneration (FTD), and Paget's disease of bone. SQSTM1/p62 protein forms liquid droplets through interaction with ubiquitinated proteins, and these droplets serve as a platform for autophagosome formation and the antioxidative stress response via the LC3-interacting region (LIR) and KEAP1-interacting region (KIR) of p62, respectively. However, it remains unclear whether ALS/FTD-related p62 mutations in the LIR and KIR disrupt liquid droplet formation leading to defects in autophagy, the stress response, or both. To evaluate the effects of ALS/FTD-related p62 mutations in the LIR and KIR on a major oxidative stress system, the Keap1-Nrf2 pathway, as well as on autophagic turnover, we developed systems to monitor each of these with high sensitivity. These methods such as intracellular protein-protein interaction assay, doxycycline-inducible gene expression system, and gene expression into primary cultured cells with recombinant adenovirus revealed that some mutants, but not all, caused reduced NRF2 activation and delayed autophagic cargo turnover. In contrast, while all p62 mutants demonstrated sufficient ability to form liquid droplets, all of these droplets also exhibited reduced inner fluidity. These results indicate that like other ALS-related mutant proteins, p62 missense mutations result in a primary defect in ALS/FTD via a qualitative change in p62 liquid droplet fluidity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Faruk</LastName><ForeName>Mohammad Omar</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Department of Physiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan; Department of Cell Physiology, Niigata University Graduate School of Medical and Dental Sciences, Chuo-ku, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichimura</LastName><ForeName>Yoshinobu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Physiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan. Electronic address: yichimu@juntendo.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kageyama</LastName><ForeName>Shun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komatsu-Hirota</LastName><ForeName>Satoko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Gowily</LastName><ForeName>Afnan H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Physiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan; Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sou</LastName><ForeName>Yu-Shin</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koike</LastName><ForeName>Masato</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noda</LastName><ForeName>Nobuo N</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Laboratory of Structural Biology, Institute of Microbial Chemistry (BIKAKEN), Shinagawa-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komatsu</LastName><ForeName>Masaaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan. Electronic address: mkomatsu@juntendo.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C431364">KEAP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C117301">Keap1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072019">Kelch-Like ECH-Associated Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495635">NFE2L2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495636">Nfe2l2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C099718">SQSTM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071456">Sequestosome-1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C101343">Sqstm1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072019" MajorTopicYN="N">Kelch-Like ECH-Associated Protein 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051267" MajorTopicYN="N">NF-E2-Related Factor 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071456" MajorTopicYN="N">Sequestosome-1 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NRF2</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">liquid droplet</Keyword><Keyword MajorTopicYN="N">p62</Keyword></KeywordList><CoiStatement>Conflict of interests We declare that we have no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>14</Day><Hour>20</Hour><Minute>48</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34774801</ArticleId><ArticleId IdType="pmc">PMC8649403</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2021.101405</ArticleId><ArticleId IdType="pii">S0021-9258(21)01212-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rea S.L., Walsh J.P., Layfield R., Ratajczak T., Xu J. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone. Endocr. Rev. 2013;34:501&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">23612225</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Purtell K., Lachance V., Wold M.S., Chen S., Yue Z. Autophagy receptors and neurodegenerative diseases. Trends Cell Biol. 2017;27:491&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">28169082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuusisto E., Salminen A., Alafuzoff I. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. Neuroreport. 2001;12:2085&#x2013;2090.</Citation><ArticleIdList><ArticleId IdType="pubmed">11447312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano T., Nakaso K., Nakashima K., Ohama E. Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: Analysis of five autopsy cases with broad clinicopathological spectrum. Acta Neuropathol. 2004;107:359&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">14762676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y., Amari M., Takatama M., Aizawa H., Mihara B., Okamoto K. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J.&#xa0;Neurol. Sci. 2006;249:13&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">16820172</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkamp S., Mostafavi S., Sachse C. Structure and function of p62/SQSTM1 in the emerging framework of phase separation. FEBS J. 2020 doi: 10.1111/febs.15672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15672</ArticleId><ArticleId IdType="pubmed">33332721</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Martin P., Saito T., Komatsu M. p62/SQSTM1: 'Jack of all trades' in health and cancer. FEBS J. 2019;286:8&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7379270</ArticleId><ArticleId IdType="pubmed">30499183</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorkoy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., Stenmark H., Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J.&#xa0;Cell Biol. 2005;171:603&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2171557</ArticleId><ArticleId IdType="pubmed">16286508</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiv S., Lamark T., Bruun J.A., Overvatn A., Bjorkoy G., Johansen T. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J.&#xa0;Biol. Chem. 2010;285:5941&#x2013;5953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820819</ArticleId><ArticleId IdType="pubmed">20018885</ArticleId></ArticleIdList></Reference><Reference><Citation>Duran A., Amanchy R., Linares J.F., Joshi J., Abu-Baker S., Porollo A., Hansen M., Moscat J., Diaz-Meco M.T. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol. Cell. 2011;44:134&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3190169</ArticleId><ArticleId IdType="pubmed">21981924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamark T., Svenning S., Johansen T. Regulation of selective autophagy: The p62/SQSTM1 paradigm. Essays Biochem. 2017;61:609&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pubmed">29233872</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejlvang J., Olsvik H., Svenning S., Bruun J.A., Abudu Y.P., Larsen K.B., Brech A., Hansen T.E., Brenne H., Hansen T., Stenmark H., Johansen T. Starvation induces rapid degradation of selective autophagy receptors by endosomal microautophagy. J.&#xa0;Cell Biol. 2018;217:3640&#x2013;3655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6168274</ArticleId><ArticleId IdType="pubmed">30018090</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., Overvatn A., Bjorkoy G., Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J.&#xa0;Biol. Chem. 2007;282:24131&#x2013;24145.</Citation><ArticleIdList><ArticleId IdType="pubmed">17580304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichimura Y., Kumanomidou T., Sou Y.S., Mizushima T., Ezaki J., Ueno T., Kominami E., Yamane T., Tanaka K., Komatsu M. Structural basis for sorting mechanism of p62 in selective autophagy. J.&#xa0;Biol. Chem. 2008;283:22847&#x2013;22857.</Citation><ArticleIdList><ArticleId IdType="pubmed">18524774</ArticleId></ArticleIdList></Reference><Reference><Citation>Turco E., Witt M., Abert C., Bock-Bierbaum T., Su M.Y., Trapannone R., Sztacho M., Danieli A., Shi X., Zaffagnini G., Gamper A., Schuschnig M., Fracchiolla D., Bernklau D., Romanov J., et al. FIP200 Claw domain binding to p62 promotes autophagosome formation at ubiquitin condensates. Mol. Cell. 2019;74:330&#x2013;346.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6477179</ArticleId><ArticleId IdType="pubmed">30853400</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuragi Y., Ichimura Y., Komatsu M. Regulation of the Keap1&#x2013;Nrf2 pathway by p62/SQSTM1. Curr. Opin. Toxicol. 2016;1:54&#x2013;61.</Citation></Reference><Reference><Citation>Sun D., Wu R., Zheng J., Li P., Yu L. Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Cell Res. 2018;28:405&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939046</ArticleId><ArticleId IdType="pubmed">29507397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaffagnini G., Savova A., Danieli A., Romanov J., Tremel S., Ebner M., Peterbauer T., Sztacho M., Trapannone R., Tarafder A.K., Sachse C., Martens S. p62 filaments capture and present ubiquitinated cargos for autophagy. EMBO J. 2018;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830917</ArticleId><ArticleId IdType="pubmed">29343546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Martin P., Komatsu M. p62/SQSTM1 - steering the cell through health and disease. J.&#xa0;Cell Sci. 2018;131</Citation><ArticleIdList><ArticleId IdType="pubmed">30397181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichimura Y., Waguri S., Sou Y.S., Kageyama S., Hasegawa J., Ishimura R., Saito T., Yang Y., Kouno T., Fukutomi T., Hoshii T., Hirao A., Takagi K., Mizushima T., Motohashi H., et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell. 2013;51:618&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">24011591</ArticleId></ArticleIdList></Reference><Reference><Citation>Kageyama S., Gudmundsson S.R., Sou Y.S., Ichimura Y., Tamura N., Kazuno S., Ueno T., Miura Y., Noshiro D., Abe M., Mizushima T., Miura N., Okuda S., Motohashi H., Lee J.A., et al. p62/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response. Nat. Commun. 2021;12:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7782522</ArticleId><ArticleId IdType="pubmed">33397898</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M., Kurokawa H., Waguri S., Taguchi K., Kobayashi A., Ichimura Y., Sou Y.S., Ueno I., Sakamoto A., Tong K.I., Kim M., Nishito Y., Iemura S., Natsume T., Ueno T., et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 2010;12:213&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">20173742</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M., Waguri S., Koike M., Sou Y.S., Ueno T., Hara T., Mizushima N., Iwata J., Ezaki J., Murata S., Hamazaki J., Nishito Y., Iemura S., Natsume T., Yanagawa T., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007;131:1149&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pubmed">18083104</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Martin P., Sou Y.S., Kageyama S., Koike M., Waguri S., Komatsu M. NBR1-mediated p62-liquid droplets enhance the Keap1-Nrf2 system. EMBO Rep. 2020;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054683</ArticleId><ArticleId IdType="pubmed">31916398</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobi A.J., Huber S.T., Mortensen S.A., Schultz S.W., Palara A., Kuhm T., Shrestha B.K., Lamark T., Hagen W.J.H., Wilmanns M., Johansen T., Brech A., Sachse C. Structural basis of p62/SQSTM1 helical filaments and their role in cellular cargo uptake. Nat. Commun. 2020;11:440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6978347</ArticleId><ArticleId IdType="pubmed">31974402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciuffa R., Lamark T., Tarafder A.K., Guesdon A., Rybina S., Hagen W.J., Johansen T., Sachse C. The selective autophagy receptor p62 forms a flexible filamentous helical scaffold. Cell Rep. 2015;11:748&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pubmed">25921531</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda N.N., Kumeta H., Nakatogawa H., Satoo K., Adachi W., Ishii J., Fujioka Y., Ohsumi Y., Inagaki F. Structural basis of target recognition by Atg8/LC3 during selective autophagy. Genes Cells. 2008;13:1211&#x2013;1218.</Citation><ArticleIdList><ArticleId IdType="pubmed">19021777</ArticleId></ArticleIdList></Reference><Reference><Citation>Nozaki M., Otomo A., Mitsui S., Ono S., Shirakawa R., Chen Y., Hama Y., Sato K., Chen X., Suzuki T., Shang H.F., Hadano S. SQSTM1(L341V) variant that is linked to sporadic ALS exhibits impaired association with MAP1LC3 in cultured cells. eNeurologicalSci. 2021;22:100301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723791</ArticleId><ArticleId IdType="pubmed">33319079</ArticleId></ArticleIdList></Reference><Reference><Citation>Goode A., Rea S., Sultana M., Shaw B., Searle M.S., Layfield R. ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling. Mol. Cell Neurosci. 2016;76:52&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062946</ArticleId><ArticleId IdType="pubmed">27554286</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright T., Rea S.L., Goode A., Bennett A.J., Ratajczak T., Long J.E., Searle M.S., Goldring C.E., Park B.K., Copple I.M., Layfield R. The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget's disease of bone. Bone. 2013;52:699&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">23117207</ArticleId></ArticleIdList></Reference><Reference><Citation>Machleidt T., Woodroofe C.C., Schwinn M.K., Mendez J., Robers M.B., Zimmerman K., Otto P., Daniels D.L., Kirkland T.A., Wood K.V. NanoBRET--a novel BRET platform for the analysis of protein-protein interactions. ACS Chem. Biol. 2015;10:1797&#x2013;1804.</Citation><ArticleIdList><ArticleId IdType="pubmed">26006698</ArticleId></ArticleIdList></Reference><Reference><Citation>Turco E., Savova A., Gere F., Ferrari L., Romanov J., Schuschnig M., Martens S. Reconstitution defines the roles of p62, NBR1 and TAX1BP1 in ubiquitin condensate formation and autophagy initiation. Nat. Commun. 2021;12:5212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410870</ArticleId><ArticleId IdType="pubmed">34471133</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi K., Yamamoto M. The KEAP1-NRF2 system as a molecular target of cancer treatment. Cancers (Basel) 2020;13:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7795874</ArticleId><ArticleId IdType="pubmed">33375248</ArticleId></ArticleIdList></Reference><Reference><Citation>Reits E.A., Neefjes J.J. From fixed to FRAP: Measuring protein mobility and activity in living cells. Nat. Cell Biol. 2001;3:E145&#x2013;E147.</Citation><ArticleIdList><ArticleId IdType="pubmed">11389456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M., Han T.W., Xie S., Shi K., Du X., Wu L.C., Mirzaei H., Goldsmith E.J., Longgood J., Pei J., Grishin N.V., Frantz D.E., Schneider J.W., Chen S., Li L., et al. Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T.W., Kato M., Xie S., Wu L.C., Mirzaei H., Pei J., Chen M., Xie Y., Allen J., Xiao G., McKnight S.L. Cell-free formation of RNA granules: Bound RNAs identify features and components of cellular assemblies. Cell. 2012;149:768&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pubmed">22579282</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., Stoynov S., Mahamid J., Saha S., Franzmann T.M., Pozniakovski A., Poser I., Maghelli N., Royer L.A., Weigert M., et al. A&#xa0;liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella A.E., Zerze G.H., Mittal J., Fawzi N.L. ALS mutations disrupt phase separation mediated by alpha-helical structure in the TDP-43 low-complexity C-terminal domain. Structure. 2016;24:1537&#x2013;1549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A.P., Kim H.J., Mittag T., Taylor J.P. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambadipudi S., Biernat J., Riedel D., Mandelkow E., Zweckstetter M. Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau. Nat. Commun. 2017;8:275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5561136</ArticleId><ArticleId IdType="pubmed">28819146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.H., Zhang P., Kim H.J., Mitrea D.M., Sarkar M., Freibaum B.D., Cika J., Coughlin M., Messing J., Molliex A., Maxwell B.A., Kim N.C., Temirov J., Moore J., Kolaitis R.M., et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167:774&#x2013;788.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Kovacs D., Konijnenberg A., Timmerman E., Volkov A., Guharoy M., De Decker M., Jaspers T., Ryan V.H., Janke A.M., Baatsen P., Vercruysse T., Kolaitis R.M., Daelemans D., et al. Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics. Mol. Cell. 2017;65:1044&#x2013;1055.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurzer B., Zaffagnini G., Fracchiolla D., Turco E., Abert C., Romanov J., Martens S. Oligomerization of p62 allows for selection of ubiquitinated cargo and isolation membrane during selective autophagy. Elife. 2015;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684078</ArticleId><ArticleId IdType="pubmed">26413874</ArticleId></ArticleIdList></Reference><Reference><Citation>Horos R., Buscher M., Kleinendorst R., Alleaume A.M., Tarafder A.K., Schwarzl T., Dziuba D., Tischer C., Zielonka E.M., Adak A., Castello A., Huber W., Sachse C., Hentze M.W. The small non-coding vault RNA1-1 acts as a riboregulator of autophagy. Cell. 2019;176:1054&#x2013;1067.e12.</Citation><ArticleIdList><ArticleId IdType="pubmed">30773316</ArticleId></ArticleIdList></Reference><Reference><Citation>Langdon E.M., Qiu Y., Ghanbari Niaki A., McLaughlin G.A., Weidmann C.A., Gerbich T.M., Smith J.A., Crutchley J.M., Termini C.M., Weeks K.M., Myong S., Gladfelter A.S. mRNA structure determines specificity of a polyQ-driven phase separation. Science. 2018;360:922&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192030</ArticleId><ArticleId IdType="pubmed">29650703</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki A., Alam J.M., Noshiro D., Hirata E., Fujioka Y., Suzuki K., Ohsumi Y., Noda N.N. Liquidity is a critical determinant for selective autophagy of protein condensates. Mol. Cell. 2020;77:1163&#x2013;1175.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31995729</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloer E.W., Siesser P.F., Cousins E.M., Goldfarb D., Mowrey D.D., Harrison J.S., Weir S.J., Dokholyan N.V., Major M.B. p62-Dependent phase separation of patient-derived KEAP1 mutations and NRF2. Mol. Cell Biol. 2018;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6206457</ArticleId><ArticleId IdType="pubmed">30126895</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanji K., Miki Y., Ozaki T., Maruyama A., Yoshida H., Mimura J., Matsumiya T., Mori F., Imaizumi T., Itoh K., Kakita A., Takahashi H., Wakabayashi K. Phosphorylation of serine 349 of p62 in Alzheimer's disease brain. Acta Neuropathol. Commun. 2014;2:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035093</ArticleId><ArticleId IdType="pubmed">24886973</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>